Use of lipid-lowering agents (statins) during pregnancy

被引：0
|
作者：
Hosokawa, A
Bar-Oz, B
Ito, S
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Family Med Program, Toronto, ON, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2003年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
QUESTION A 34-year-old patient of mine is taking a "strain" for hyperlipidemia. She is planning pregnancy and is worried about the safety of the drug. How should I advise her? ANSWER Limited evidence from animal and human studies indicates that statins should not be taken during pregnancy. If a patient is inadvertently exposed during pregnancy, however, termination does not appear to be medically indicated.
引用
收藏
页码：747 / 749
页数：3
相关论文
共 50 条
  • [41] The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular Disease
    Rysz, Jacek
    Franczyk, Beata
    Olszewski, Robert
    Banach, Maciej
    Gluba-Brzozka, Anna
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (17) : 2488 - 2495
  • [42] The short-circuit evidence on lipid-lowering drugs use in pregnancy
    Fogacci, Federica
    Borghi, Claudio
    Cicero, Arrigo F. G.
    ATHEROSCLEROSIS, 2023, 368 : 12 - 13
  • [43] Natural lipid-lowering agents and their effects: an update
    Saghir, Sultan Ayesh Mohammed
    Revadigar, Vageesh
    Murugaiyah, Vikneswaran
    EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2014, 238 (05) : 705 - 725
  • [44] Lipid-lowering agents and artery endothelial function
    Inoue, K
    Kawahito, Y
    Yoshikawa, T
    Sano, H
    CHEST, 2001, 119 (06) : 1979 - 1979
  • [45] Natural lipid-lowering agents and their effects: an update
    Sultan Ayesh Mohammed Saghir
    Vageesh Revadigar
    Vikneswaran Murugaiyah
    European Food Research and Technology, 2014, 238 : 705 - 725
  • [46] Prospective analysis of association between use of statins or other lipid-lowering agents and melanoma risk in the Women's Health Initiative
    Jagtap, D. B.
    Rosenberg, C. A.
    Martin, L.
    Pettinger, M.
    Greenland, P.
    Khandekar, J. D.
    Levy, R.
    Lane, D.
    Simon, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Myopathies under therapy with lipid-lowering agents
    Köller, H
    Neuhaus, O
    Schroeter, M
    Hartung, H
    NERVENARZT, 2005, 76 (02): : 212 - 217
  • [48] FLUVASTATIN IN COMBINATION WITH OTHER LIPID-LOWERING AGENTS
    JOKUBAITIS, LA
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1994, : 28 - 32
  • [49] Lipid-lowering agents and cognitive decline in AD
    Christine Kyme
    Nature Clinical Practice Neurology, 2006, 2 (3): : 121 - 122
  • [50] Xanthoma disseminatum treated with lipid-lowering agents
    Michelle Doria-Perez, Karla
    Alfredo Soto-Ortiz, Jose
    Berenice Matildes-Mariscal, Jessica
    Gabriel Barrientos-Garcia, Juan
    Javier Salazar-Torres, Francisco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB314 - AB314
12345